Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Michael, Deininger"'
Autor:
Jorge Cortes, Michael Deininger, Elza Lomaia, Beatriz Moiraghi, Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James Mccloskey, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Christine Rojas, Anna Turkina, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane Apperley
Publikováno v:
HemaSphere, Vol 7, p e85501cf (2023)
Externí odkaz:
https://doaj.org/article/f0b8d7a160ec4ce1b84d936813ace846
Autor:
Martin C. Müller, Jorge Cortes, Charles Chuah, Daniel Deangelo, Michael Deininger, François Guilhot, Timothy Hughes, Franck Emmanuel Nicolini, Javier Pinilla-Ibarz, Delphine Rea, Gianantonio Rosti, Neil P. Shah, Moshe Talpaz, Vickie Lu, Thihan Padukkavidana, Hagop Kantarjian
Publikováno v:
HemaSphere, Vol 7, p e88427a9 (2023)
Externí odkaz:
https://doaj.org/article/eb3dd58a194242debe7a5d6162af5c8c
Autor:
Jason Gotlib, Andreas Reiter, Deepti Radia, Michael Deininger, Tracy George, Jens Panse, Alessandro Vannucchi, Uwe Platzbecker, Ivan Alvarez-Twose, Andrzej Mital, Olivier Hermine, Ingunn Dybedal, Elizabeth O. Hexner, Lambert Span, Ruben Mesa, Prithviraj Bose, Kirsten Pettit, Stephen Oh, Hui-Min Lin, Sasa Dimitrijevic, Javier Muñoz-González, Daniel J. Deangelo
Publikováno v:
HemaSphere, Vol 7, p e3184876 (2023)
Externí odkaz:
https://doaj.org/article/8d55f7aefc814a2483dddc9524d3fbe7
Autor:
James L. Januzzi, Joseph M. Garasic, Scott E. Kasner, Vickie McDonald, Mark C. Petrie, Jonathan Seltzer, Michael Mauro, Kevin Croce, Ellin Berman, Michael Deininger, Andreas Hochhaus, Javier Pinilla-Ibarz, Franck Nicolini, Dong-Wook Kim, Daniel J. DeAngelo, Hagop Kantarjian, Jing Xu, Tracey Hall, Shouryadeep Srivastava, Daniel Naranjo, Jorge Cortes
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-25 (2022)
Abstract Background The phase 2 PACE (Ponatinib Ph+ ALL and CML Evaluation) trial of ponatinib showed robust long-term benefit in relapsed Philadelphia chromosome-positive (Ph+) leukemia; arterial occlusive events (AOEs) occurred in ≥ 25% of patien
Externí odkaz:
https://doaj.org/article/7426e5d81482431bb46fd0f35d6ca6ed
Autor:
Jerald P. Radich, Matthew Wall, Susan Branford, Catarina D. Campbell, Shalini Chaturvedi, Daniel J. DeAngelo, Michael Deininger, Justin Guinney, Andreas Hochhaus, Timothy P Hughes, Hagop M. Kantarjian, Richard A. Larson, Sai Li, Rodrigo Maegawa, Kaushal Mishra, Vanessa Obourn, Javier Pinilla-Ibarz, Das Purkayastha, Islam Sadek, Giuseppe Saglio, Alok Shrestha, Brian S. White, Brian J. Druker
Publikováno v:
Haematologica, Vol 108, Iss 6 (2023)
Tyrosine kinase inhibitor therapy revolutionized chronic myeloid leukemia treatment and showed how targeted therapy and molecular monitoring could be used to substantially improve survival outcomes. We used chronic myeloid leukemia as a model to unde
Externí odkaz:
https://doaj.org/article/0ea048e8ba4f46a6a15bd5a4b185ec55
Autor:
Michael Deininger, Frank McDermott, Francisco W. Cruz, Juan Pablo Bernal, Manfred Mudelsee, Hubert Vonhof, Christian Millo, Christoph Spötl, Pauline C. Treble, Robyn Pickering, Denis Scholz
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Solar insolation is not equally distributed on the Earth’s surface and such imbalances influence the atmospheric circulation. Here, the authors show that latitudinal insolation gradients synchronized the hydroclimate in the Northern mid-latitudes a
Externí odkaz:
https://doaj.org/article/2db0c7f7b86943d0a275cc756698d521
Autor:
Mathias Schneeweiss-Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, Daniela Berger, Gregor Eisenwort, Chantal Blanche Lucini, Susanne Herndlhofer, Sandra Preuner, Klara Obrova, Petra Pusic, Nadine Witzeneder, Georg Greiner, Gregor Hoermann, Wolfgang R. Sperr, Thomas Lion, Michael Deininger, Peter Valent, Karoline V. Gleixner
Publikováno v:
EBioMedicine, Vol 50, Iss , Pp 111-121 (2019)
Purpose: Ponatinib is the only approved tyrosine kinase inhibitor (TKI) suppressing BCR-ABL1T315I-mutated cells in chronic myeloid leukemia (CML). However, due to side effects and resistance, BCR-ABL1T315I-mutated CML remains a clinical challenge. Hy
Externí odkaz:
https://doaj.org/article/fbb9dd16496d4e52a309a4b4f40496e3
Autor:
Michael Deininger, Denis Scholz
Publikováno v:
International Journal of Speleology, Vol 48, Iss 1, Pp 21-32 (2019)
Stable oxygen and carbon isotope ratios (δ13C and δ18O) are the most applied climate and environmental proxies in speleothems allowing to infer past changes in cave drip water δ13C and δ18O related to climate and environmental variations from abo
Externí odkaz:
https://doaj.org/article/fe5444f20e284093b41aab899cdb2445
Autor:
Antoine N. Saliba, Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, Tara L. Lin, Brian J. Ball, Michael M. Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha L. Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Kevin L. Peterson, Paula A. Schneider, Molly Martycz, Theophilus J. Gana, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy Chen, Mona Stefanos, Alice S. Mims, Uma Borate, Amy Burd, Brian J. Druker, Ross L. Levine, John C. Byrd, James M. Foran
Publikováno v:
Blood Advances. 7:2360-2363
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492444b38fef8304f0e0d1fa33a7f531
https://doi.org/10.1182/bloodadvances.2022008625
https://doi.org/10.1182/bloodadvances.2022008625
Autor:
Peter Valent, Alberto Orfao, Stefan Kubicek, Philipp Staber, Torsten Haferlach, Michael Deininger, Karoline Kollmann, Thomas Lion, Irene Virgolini, Georg Winter, Oliver Hantschel, Lukas Kenner, Johannes Zuber, Florian Grebien, Richard Moriggl, Gregor Hoermann, Olivier Hermine, Michael Andreeff, Christoph Bock, Tariq Mughal, Stefan N. Constantinescu, Robert Kralovics, Veronika Sexl, Radek Skoda, Giulio Superti-Furga, Ulrich Jäger
Publikováno v:
HemaSphere, Vol 5, Iss 3, p e536 (2021)
During the past few years, our understanding of molecular mechanisms and cellular interactions relevant to malignant blood cell disorders has improved substantially. New insights include a detailed knowledge about disease-initiating exogenous factors
Externí odkaz:
https://doaj.org/article/f83af71379764078b058a0d468ded29b